{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T10:19:57Z","timestamp":1786184397089,"version":"3.56.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"vor","delay-in-days":255,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"publisher","award":["634143"],"award-info":[{"award-number":["634143"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["716063"],"award-info":[{"award-number":["716063"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["272577"],"award-info":[{"award-number":["272577"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["277293"],"award-info":[{"award-number":["277293"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["295504"],"award-info":[{"award-number":["295504"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["292611"],"award-info":[{"award-number":["292611"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["310507"],"award-info":[{"award-number":["310507"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["313267"],"award-info":[{"award-number":["313267"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006383","name":"Cancer Society of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sigrid Juselius Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/database\/bay083","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T18:52:49Z","timestamp":1532026369000},"source":"Crossref","is-referenced-by-count":56,"title":["Drug Target Commons 2.0: a community platform for systematic analysis of drug\u2013target interaction profiles"],"prefix":"10.1093","volume":"2018","author":[{"given":"ZiaurRehman","family":"Tanoli","sequence":"first","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Alam","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"V\u00e4h\u00e4-Koskela","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaguru","family":"Ravikumar","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Malyutina","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Jaiswal","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"},{"name":"Department of Mathematics and Statistics, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krister","family":"Wennerberg","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"},{"name":"Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Aittokallio","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland"},{"name":"Department of Mathematics and Statistics, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"key":"key\n\t\t\t\t2018122817282756900_ref1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1039\/b905821b","article-title":"The topology of drug\u2013target interaction networks: implicit dependence on drug properties and target families","volume":"5","author":"Mestres","year":"2009","journal-title":"Mol. Biosyst."},{"key":"key\n\t\t\t\t2018122817282756900_ref2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nbt1228","article-title":"Global mapping of pharmacological space","volume":"24","author":"Paolini","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t2018122817282756900_ref4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018122817282756900_ref5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005678","article-title":"Computational-experimental approach to drug-target interaction mapping: a case study on kinase inhibitors","volume":"13","author":"Cichonska","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t2018122817282756900_ref6","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4368","article-title":"The target landscape of clinical kinase drugs","volume":"358","author":"Klaeger","year":"2017","journal-title":"Science"},{"key":"key\n\t\t\t\t2018122817282756900_ref7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/17460441.2018.1413089","article-title":"Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery","volume":"13","author":"Ravikumar","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"key\n\t\t\t\t2018122817282756900_ref8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nmeth.4457","article-title":"The inconvenience of data of convenience: computational research beyond post-mortem analyses","volume":"14","author":"Azencott","year":"2017","journal-title":"Nat. Methods."},{"key":"key\n\t\t\t\t2018122817282756900_ref9","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref10","article-title":"PubChem bioassay: 2014 update","volume":"42","author":"Wang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2018122817282756900_ref11","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref12","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref13","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13882","article-title":"The concise guide to PHARMACOLOGY 2017\/18: overview","volume":"174","author":"Alexander","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"key\n\t\t\t\t2018122817282756900_ref14","article-title":"DGIdb 2.0: mining clinically relevant drug\u2013gene interactions","volume":"44","author":"Wagner","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2018122817282756900_ref15","doi-asserted-by":"crossref","first-page":"D1069","DOI":"10.1093\/nar\/gkv1230","article-title":"Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information","volume":"44","author":"Yang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/nar\/30.1.163","article-title":"PharmGKB: the pharmacogenetics knowledge base","volume":"30","author":"Hewett","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nchembio.1867","article-title":"The promise and peril of chemical probes","volume":"11","author":"Arrowsmith","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"key\n\t\t\t\t2018122817282756900_ref18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.chembiol.2017.11.004","article-title":"Objective, quantitative, data-driven assessment of chemical probes","volume":"25","author":"Antolin","year":"2017","journal-title":"Cell Chem. Biol"},{"key":"key\n\t\t\t\t2018122817282756900_ref19","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t2018122817282756900_ref20","article-title":"Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"key":"key\n\t\t\t\t2018122817282756900_ref21","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw041","article-title":"The drug-minded protein interaction database (DrumPID) for efficient target analysis and drug development","volume":"2016","author":"Kunz","year":"2016","journal-title":"Database"},{"key":"key\n\t\t\t\t2018122817282756900_ref22","doi-asserted-by":"crossref","first-page":"W21","DOI":"10.1093\/nar\/gkm298","article-title":"iHOP web services","volume":"35","author":"Fernandez","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.drudis.2012.05.016","article-title":"Open PHACTS: semantic interoperability for drug discovery","volume":"17","author":"Williams","year":"2012","journal-title":"Drug Discov. Today"},{"key":"key\n\t\t\t\t2018122817282756900_ref24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drudis.2015.08.001","article-title":"Identifying compound efficacy targets in phenotypic drug discovery","volume":"21","author":"Schirle","year":"2016","journal-title":"Drug Discov. Today"},{"key":"key\n\t\t\t\t2018122817282756900_ref25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chembiol.2017.11.009","article-title":"Drug Target Commons: a community effort to build a consensus knowledge base for drug-target interactions","volume":"25","author":"Tang","year":"2017","journal-title":"Cell Chem. Biol"},{"key":"key\n\t\t\t\t2018122817282756900_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2041-1480-5-S1-S5","article-title":"Evolving BioAssay Ontology (BAO): modularization, integration and applications","volume":"5","author":"Abeyruwan","year":"2014","journal-title":"J. Biomed. Semantics"},{"key":"key\n\t\t\t\t2018122817282756900_ref27","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref28","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-018-0531-8","article-title":"Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations","volume-title":"Genome medicine","author":"Tamborero","year":"2018"},{"key":"key\n\t\t\t\t2018122817282756900_ref29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ddtec.2015.01.005","article-title":"Chemical databases: curation or integration by user-defined equivalence?","volume":"14","author":"Hersey","year":"2015","journal-title":"Drug Discov. Today Technol."},{"key":"key\n\t\t\t\t2018122817282756900_ref30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12859-017-1785-7","article-title":"MediSyn: uncertainty-aware visualization of multiple biomedical datasets to support drug treatment selection","volume":"18","author":"He","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"key\n\t\t\t\t2018122817282756900_ref31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t2018122817282756900_ref32","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1200\/JCO.2010.28.9678","article-title":"Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3","volume":"28","author":"Fischer","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t2018122817282756900_ref33","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1182\/blood-2009-03-208298","article-title":"Compassionate use of sorafenib in FLT3-ITD\u2013positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation","volume":"113","author":"Metzelder","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018122817282756900_ref34","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1182\/blood-2011-06-363960","article-title":"Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation","volume":"119","author":"Man","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018122817282756900_ref35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature14119","article-title":"Axitinib effectively inhibits BCR-ABL1 (T315I) with a distinct binding conformation","volume":"519","author":"Pemovska","year":"2015","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018122817282756900_ref36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cell.2016.01.045","article-title":"Exploiting temporal collateral sensitivity in tumor clonal evolution","volume":"165","author":"Zhao","year":"2016","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018122817282756900_ref37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.leukres.2008.09.027","article-title":"Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V","volume":"33","author":"Ustun","year":"2009","journal-title":"Leuk. Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref38","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2007.14.0707","article-title":"Major response to imatinib mesylate in KIT-mutated melanoma","volume":"26","author":"Hodi","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t2018122817282756900_ref39","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018122817282756900_ref40","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1200\/JCO.2010.33.9275","article-title":"Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification","volume":"29","author":"Guo","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t2018122817282756900_ref41","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-11-1987","article-title":"Sunitinib therapy for melanoma patients with KIT mutations","volume":"18","author":"Minor","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref42","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s10637-011-9763-9","article-title":"Nilotinib in patients with metastatic melanoma harboring KIT gene aberration. Invest","volume":"30","author":"Cho","year":"2012","journal-title":"New Drugs"},{"key":"key\n\t\t\t\t2018122817282756900_ref43","doi-asserted-by":"crossref","first-page":"W495","DOI":"10.1093\/nar\/gkx384","article-title":"C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrograms","volume":"45","author":"Ravikumar","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2018122817282756900_ref44","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-17-3644","article-title":"Patient-customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients","volume":"78","author":"He","year":"2018","journal-title":"Cancer Res"}],"container-title":["Database"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/bay083\/27329150\/bay083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T21:34:51Z","timestamp":1571607291000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/database\/article\/doi\/10.1093\/database\/bay083\/5096727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":44,"URL":"https:\/\/doi.org\/10.1093\/database\/bay083","relation":{},"ISSN":["1758-0463"],"issn-type":[{"value":"1758-0463","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018]]},"published":{"date-parts":[[2018,1,1]]}}}